277 related articles for article (PubMed ID: 14732752)
1. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation.
Xu J; Cui G; Esmailian F; Plunkett M; Marelli D; Ardehali A; Odim J; Laks H; Sen L
Circulation; 2004 Jan; 109(3):363-8. PubMed ID: 14732752
[TBL] [Abstract][Full Text] [Related]
2. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR
Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051
[TBL] [Abstract][Full Text] [Related]
3. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
[TBL] [Abstract][Full Text] [Related]
5. [Clinical on molecular basis of atrial fibrosis in patients with atrial fibrillation investigation].
Ke D; Xu CX; Lin YZ; Zhang JC; Chen L; Lin LF; Hu XZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):459-63. PubMed ID: 15932710
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure.
Moe GW; Laurent G; Doumanovskaia L; Konig A; Hu X; Dorian P
J Card Fail; 2008 Nov; 14(9):768-76. PubMed ID: 18995182
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
[TBL] [Abstract][Full Text] [Related]
8. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
Nakano Y; Niida S; Dote K; Takenaka S; Hirao H; Miura F; Ishida M; Shingu T; Sueda T; Yoshizumi M; Chayama K
J Am Coll Cardiol; 2004 Mar; 43(5):818-25. PubMed ID: 14998623
[TBL] [Abstract][Full Text] [Related]
11. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
Zhu H; Zhang W; Guo CH; Zhang G; Zhang WD; Zhong M; Yang GR; Ge ZM; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):45-8. PubMed ID: 15808077
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.
Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Arfanakis DA; Maliaraki NE; Lathourakis CE; Chlouverakis GI; Vardas PE
J Am Coll Cardiol; 2008 Jul; 52(3):211-5. PubMed ID: 18617070
[TBL] [Abstract][Full Text] [Related]
13. Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases.
Qian Y; Meng J; Tang H; Yang G; Deng Y; Wei D; Xiang B; Xiao X
Europace; 2010 Mar; 12(3):371-7. PubMed ID: 20106797
[TBL] [Abstract][Full Text] [Related]
14. [Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation].
Wang W; Wu PS; Yang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1160-2. PubMed ID: 20501421
[TBL] [Abstract][Full Text] [Related]
15. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Wang W; Zhang HT; Yang XL
J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation.
Gramley F; Lorenzen J; Plisiene J; Rakauskas M; Benetis R; Schmid M; Autschbach R; Knackstedt C; Schimpf T; Mischke K; Gressner A; Hanrath P; Kelm M; Schauerte P
J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1076-82. PubMed ID: 17655664
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme.
Zhang W; Zhong M; Yang GR; Li JP; Guo C; Wang Z; Zhang Y
Cardiovasc Pathol; 2008; 17(6):399-409. PubMed ID: 18706834
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
19. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
[TBL] [Abstract][Full Text] [Related]
20. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.
Marín F; Pascual DA; Roldán V; Arribas JM; Ahumada M; Tornel PL; Oliver C; Gómez-Plana J; Lip GY; Valdés M
Am J Cardiol; 2006 Jan; 97(1):55-60. PubMed ID: 16377284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
